Acute Myeloid Leukemia: Examining the Pharmacologic Profiles and Integration of Treatment Advances

  Рет қаралды 5,138

HMP Education

HMP Education

Күн бұрын

Earn CME for related activities: www.naccme.com/oln
Featuring a presentation by Dr. Christopher A. Fausel, this on-demand webcast examines novel chemotherapeutic formulations and targeted agents in the treatment of AML in terms of clinical outcomes, pharmacologic profiles, reduced toxicity, and pharmacoeconomic data.
© 2018 NACCME, an HMP Company

Пікірлер: 1
@prankrishnanath5080
@prankrishnanath5080 4 жыл бұрын
Thank you.
Newly diagnosed AML: Hitting the right target
29:07
HMP Education
Рет қаралды 8 М.
Мы никогда не были так напуганы!
00:15
Аришнев
Рет қаралды 6 МЛН
Жайдарман | Туған күн 2024 | Алматы
2:22:55
Jaidarman OFFICIAL / JCI
Рет қаралды 1,8 МЛН
Sandra's Acute Myeloid Leukaemia Story
4:37
Leukaemia Care
Рет қаралды 14 М.
Biomarkers for treatment selection in colon cancer
22:49
HMP Education
Рет қаралды 11 М.
IBS-D: Pathophysiology and Treatment
22:37
HMP Education
Рет қаралды 45 М.
MRD in AML: What is it and what do I do about it?
24:36
HMP Education
Рет қаралды 7 М.
Acute Myelogenous Leukemia AML: Transplant or Not?
22:25
Leukemia Research Foundation
Рет қаралды 8 М.
MRD in Acute Myeloid Leukemia
31:31
HMP Education
Рет қаралды 9 М.
Myeloid neoplasms - AML, MDS, CML, MPNs
39:53
Pathology Basics
Рет қаралды 1,8 М.
Diagnosis and treatment of newly diagnosed ALL
20:56
HMP Education
Рет қаралды 13 М.
Мы никогда не были так напуганы!
00:15
Аришнев
Рет қаралды 6 МЛН